ID   KAD7_HUMAN              Reviewed;         723 AA.
AC   Q96M32; Q8IYP6;
DT   03-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   24-NOV-2009, sequence version 3.
DT   10-MAY-2017, entry version 134.
DE   RecName: Full=Adenylate kinase 7;
DE            Short=AK 7;
DE            EC=2.7.4.3 {ECO:0000269|PubMed:21080915, ECO:0000269|PubMed:23416111};
DE            EC=2.7.4.6 {ECO:0000269|PubMed:23416111};
DE   AltName: Full=ATP-AMP transphosphorylase 7;
GN   Name=AK7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS GLN-102 AND
RP   LYS-389.
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   CATALYTIC ACTIVITY.
RX   PubMed=21080915; DOI=10.1042/BJ20101443;
RA   Panayiotou C., Solaroli N., Xu Y., Johansson M., Karlsson A.;
RT   "The characterization of human adenylate kinases 7 and 8 demonstrates
RT   differences in kinetic parameters and structural organization among
RT   the family of adenylate kinase isoenzymes.";
RL   Biochem. J. 433:527-534(2011).
RN   [4]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=23416111; DOI=10.1016/j.biocel.2013.02.004;
RA   Amiri M., Conserva F., Panayiotou C., Karlsson A., Solaroli N.;
RT   "The human adenylate kinase 9 is a nucleoside mono- and diphosphate
RT   kinase.";
RL   Int. J. Biochem. Cell Biol. 45:925-931(2013).
CC   -!- FUNCTION: Nucleoside monophosphate (NMP) kinase that catalyzes the
CC       reversible transfer of the terminal phosphate group between
CC       nucleoside triphosphates and monophosphates. Has highest activity
CC       toward AMP, and weaker activity toward dAMP, CMP and dCMP. Also
CC       displays broad nucleoside diphosphate kinase activity. Involved in
CC       maintaining ciliary structure and function.
CC       {ECO:0000269|PubMed:21080915, ECO:0000269|PubMed:23416111}.
CC   -!- CATALYTIC ACTIVITY: ATP + AMP = 2 ADP.
CC       {ECO:0000269|PubMed:21080915, ECO:0000269|PubMed:23416111}.
CC   -!- CATALYTIC ACTIVITY: ATP + nucleoside diphosphate = ADP +
CC       nucleoside triphosphate. {ECO:0000269|PubMed:23416111}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.0 uM for AMP {ECO:0000269|PubMed:21080915};
CC         KM=28 uM for dAMP {ECO:0000269|PubMed:21080915};
CC         KM=1.2 uM for CMP {ECO:0000269|PubMed:21080915};
CC         Vmax=1130 pmol/min/ug enzyme with AMP as substrate
CC         {ECO:0000269|PubMed:21080915};
CC         Vmax=860 pmol/min/ug enzyme with dAMP as substrate
CC         {ECO:0000269|PubMed:21080915};
CC         Vmax=150 pmol/min/ug enzyme with CMP as substrate
CC         {ECO:0000269|PubMed:21080915};
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:21080915}.
CC   -!- SIMILARITY: In the central section; belongs to the adenylate
CC       kinase family. {ECO:0000305}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the dpy-30
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK057426; BAB71480.1; -; mRNA.
DR   EMBL; AL163051; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL359240; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS9945.1; -.
DR   RefSeq; NP_689540.2; NM_152327.3.
DR   UniGene; Hs.667462; -.
DR   ProteinModelPortal; Q96M32; -.
DR   SMR; Q96M32; -.
DR   BioGrid; 125773; 4.
DR   IntAct; Q96M32; 4.
DR   STRING; 9606.ENSP00000267584; -.
DR   iPTMnet; Q96M32; -.
DR   PhosphoSitePlus; Q96M32; -.
DR   BioMuta; AK7; -.
DR   DMDM; 269849674; -.
DR   EPD; Q96M32; -.
DR   PaxDb; Q96M32; -.
DR   PeptideAtlas; Q96M32; -.
DR   PRIDE; Q96M32; -.
DR   DNASU; 122481; -.
DR   Ensembl; ENST00000267584; ENSP00000267584; ENSG00000140057.
DR   GeneID; 122481; -.
DR   KEGG; hsa:122481; -.
DR   UCSC; uc001yfn.3; human.
DR   CTD; 122481; -.
DR   DisGeNET; 122481; -.
DR   GeneCards; AK7; -.
DR   H-InvDB; HIX0011951; -.
DR   HGNC; HGNC:20091; AK7.
DR   HPA; HPA003543; -.
DR   MIM; 615364; gene.
DR   neXtProt; NX_Q96M32; -.
DR   OpenTargets; ENSG00000140057; -.
DR   PharmGKB; PA134963502; -.
DR   eggNOG; KOG3078; Eukaryota.
DR   eggNOG; COG0563; LUCA.
DR   GeneTree; ENSGT00390000015102; -.
DR   HOGENOM; HOG000007764; -.
DR   HOVERGEN; HBG045568; -.
DR   InParanoid; Q96M32; -.
DR   KO; K00939; -.
DR   OMA; KMAWLGE; -.
DR   OrthoDB; EOG091G0MZX; -.
DR   PhylomeDB; Q96M32; -.
DR   TreeFam; TF313982; -.
DR   Reactome; R-HSA-499943; Synthesis and interconversion of nucleotide di- and triphosphates.
DR   ChiTaRS; AK7; human.
DR   GenomeRNAi; 122481; -.
DR   PRO; PR:Q96M32; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000140057; -.
DR   CleanEx; HS_AK7; -.
DR   ExpressionAtlas; Q96M32; baseline and differential.
DR   Genevisible; Q96M32; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0004017; F:adenylate kinase activity; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004127; F:cytidylate kinase activity; IDA:UniProtKB.
DR   GO; GO:0004550; F:nucleoside diphosphate kinase activity; IDA:UniProtKB.
DR   GO; GO:0019206; F:nucleoside kinase activity; EXP:Reactome.
DR   GO; GO:0030030; P:cell projection organization; IEA:UniProtKB-KW.
DR   GO; GO:0015949; P:nucleobase-containing small molecule interconversion; TAS:Reactome.
DR   GO; GO:0006165; P:nucleoside diphosphate phosphorylation; IDA:UniProtKB.
DR   GO; GO:0009142; P:nucleoside triphosphate biosynthetic process; IDA:UniProtKB.
DR   CDD; cd01428; ADK; 1.
DR   InterPro; IPR000850; Adenylat/UMP-CMP_kin.
DR   InterPro; IPR026867; AK7.
DR   InterPro; IPR007858; Dpy-30_motif.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR23359; PTHR23359; 1.
DR   PANTHER; PTHR23359:SF133; PTHR23359:SF133; 1.
DR   Pfam; PF05186; Dpy-30; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cilium biogenesis/degradation; Coiled coil;
KW   Complete proteome; Cytoplasm; Kinase; Nucleotide-binding;
KW   Polymorphism; Reference proteome; Transferase.
FT   CHAIN         1    723       Adenylate kinase 7.
FT                                /FTId=PRO_0000158952.
FT   NP_BIND     377    382       ATP. {ECO:0000250|UniProtKB:P69441}.
FT   NP_BIND     432    455       AMP. {ECO:0000250|UniProtKB:P69441}.
FT   NP_BIND     482    485       AMP. {ECO:0000250|UniProtKB:P69441}.
FT   REGION      367    612       Adenylate kinase.
FT                                {ECO:0000305|PubMed:21080915}.
FT   REGION      397    455       NMPbind. {ECO:0000250|UniProtKB:P69441}.
FT   REGION      537    547       LID. {ECO:0000250|UniProtKB:P69441}.
FT   REGION      679    723       DPY-30. {ECO:0000305|PubMed:21080915}.
FT   COILED       46    458       {ECO:0000255}.
FT   COILED      609    677       {ECO:0000255}.
FT   COMPBIAS      3      6       Poly-Glu.
FT   COMPBIAS     51     58       Poly-Glu.
FT   COMPBIAS    420    432       Poly-Glu.
FT   COMPBIAS    497    502       Poly-Glu.
FT   COMPBIAS    616    674       Glu-rich.
FT   BINDING     489    489       AMP. {ECO:0000250|UniProtKB:P69441}.
FT   BINDING     555    555       AMP. {ECO:0000250|UniProtKB:P69441}.
FT   BINDING     587    587       ATP; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:P69441}.
FT   VARIANT     102    102       R -> Q (in dbSNP:rs2275554).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_017059.
FT   VARIANT     389    389       N -> K (in dbSNP:rs2369679).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_057950.
FT   CONFLICT    272    272       P -> L (in Ref. 1; BAB71480).
FT                                {ECO:0000305}.
FT   CONFLICT    410    410       E -> G (in Ref. 1; BAB71480).
FT                                {ECO:0000305}.
SQ   SEQUENCE   723 AA;  82658 MW;  7A9E2BF11A4CEEF8 CRC64;
     MAEEEETAAL TEKVIRTQRV FINLLDSYSS GNIGKFLSNC VVGASLEEIT EEEEEEDENK
     SAMLEASSTK VKEGTFQIVG TLSKPDSPRP DFAVETYSAI SREDLLMRLL ECDVIIYNIT
     ESSQQMEEAI WAVSALSEEV SHFEKRKLFI LLSTVMTWAR SKALDPEDSE VPFTEEDYRR
     RKSHPNFLDH INAEKMVLKF GKKARKFAAY VVAAGLQYGA EGGMLHTFFK MAWLGEIPAL
     PVFGDGTNVI PTIHVLDLAG VIQNVIDHVP KPHYLVAVDE SVHTLEDIVK CISKNTGPGK
     IQKIPRENAY LTKDLTQDCL DHLLVNLRME ALFVKENFNI RWAAQTGFVE NINTILKEYK
     QSRGLMPIKI CILGPPAVGK SSIAKELANY YKLHHIQLKD VISEAIAKLE AIVAPNDVGE
     GEEEVEEEEE EENVEDAQEL LDGIKESMEQ NAGQLDDQYI IRFMKEKLKS MPCRNQGYIL
     DGFPKTYDQA KDLFNQEDEE EEDDVRGRMF PFDKLIIPEF VCALDASDEF LKERVINLPE
     SIVAGTHYSQ DRFLRALSNY RDINIDDETV FNYFDELEIH PIHIDVGKLE DAQNRLAIKQ
     LIKEIGEPRN YGLTDEEKAE EERKAAEERL AREAAEEAER EHQEAVEMAE KIARWEEWNK
     RLEEVKREER ELLEAQSIPL RNYLMTYVMP TLIQGLNECC NVRPEDPVDF LAEYLFKNNP
     EAQ
//
